Gaudium IVF & Women Health
119.93
+4.86(+4.22%)
Market Cap₹872.93 Cr
PE Ratio36.88
IndustryHealthcare
Company Performance:
1D+4.22%
1M+1.99%
6M+49.43%
1Y+49.43%
5Y+49.43%
View Company Insightsright
More news about Gaudium IVF & Women Health
08Apr 26
Gaudium IVF Submits Additional Arbitration Disclosures Following BSE Query
Gaudium IVF & Women Health Limited provided comprehensive disclosures following BSE's query on arbitration proceedings involving ₹29.21 crore claim by Neomile Corporate Advisory. Bombay High Court appointed Justice Nitin Jamdar as sole arbitrator on April 02, 2026, with company explaining disclosure delay due to weekend court order upload.
 no imag found
02Apr 26
Gaudium IVF Launches AI-Led Infertility Treatment in Industry-First Initiative
Gaudium IVF and Women Health Limited has launched AI-led infertility treatment in an industry-first initiative for India. The company has integrated advanced AI-driven embryology systems SiD and ERICA into clinical practice through collaboration with UK-based IVF 2.0. The milestone was inaugurated by Union Minister Shri Nitin Jairam Gadkari on April 1st, 2026, with early observations suggesting significant improvements in fertilisation and blastocyst development rates.
 no imag found
19Mar 26
Gaudium IVF And Women Health Claims Significant Growth Potential In India's Fertility Care Sector
Gaudium IVF And Women Health claims significant growth potential in India's fertility care sector and aims to establish leadership through expanded access and improved outcomes. The company is focusing on building a trusted fertility network to serve the growing demand for specialized reproductive health services across the country.
 no imag found
19Mar 26
Gaudium IVF Reports Q3 FY26 Revenue of ₹245.07 Crores in First Post-IPO Results
Gaudium IVF & Women Health Limited announced strong Q3 FY26 results with consolidated revenue of ₹245.07 crores showing 70.19% year-over-year growth and net profit of ₹36.31 crores. The results mark the company's first earnings announcement following its successful IPO completion and listing on NSE and BSE on February 27, 2026, after raising approximately ₹1,650.01 crores.
 no imag found
18Mar 26
Gaudium IVF Appoints New Internal and Secretarial Auditors for FY 2025-26
Gaudium IVF and Women Health Limited appointed M/s. Ram Rattan & Associates as Internal Auditors and M/s. Suresh Nainwal & Company as Secretarial Auditors for FY 2025-26. The appointments were approved during a board meeting on March 18, 2026, based on Audit Committee recommendations and comply with SEBI regulations.
 no imag found
Gaudium IVF & Women Health
119.93
+4.86
(+4.22%)
1 Year Returns:+49.43%
Industry Peers
Dr. Lal Path Labs
1,614.90
(-0.93%)
Vijaya Diagnostic Centre
1,220.40
(-0.55%)
Metropolis Healthcare
524.50
(+1.07%)
Krsnaa Diagnostics
553.85
(-1.55%)
Suraksha Diagnostic
298.50
(-4.69%)
3B BlackBio DX
1,236.20
(+2.50%)
Health X Platform
322.45
(+11.56%)